Federal scientists are buying baboons to infect them with whooping cough so they can test vaccines and transmission in a Maryland lab, using taxpayer dollars.
Story Snapshot
- Food and Drug Administration researchers call baboons the only model that mirrors human coughing and spread.
- Studies show vaccines can block disease symptoms in baboons but not colonization or transmission.
- An approved internal protocol signals an active, ongoing pertussis program at the agency.
- Public records do not show the specific purchase details, like vendor, age, or cost.
What FDA Scientists Are Doing And Why It Matters
Food and Drug Administration researchers use a baboon model to study whooping cough, also called pertussis. Agency-linked papers say baboons are the first animal to show human-like coughing and person-to-person style spread. That feature lets scientists track how the germ moves and how vaccines work in real life conditions, not just in blood tests. Their reports describe the model as a tool to study disease, review current vaccines, and design better ones.
Food and Drug Administration publications state the baboon model recreates the full set of human symptoms, including coughing and transmission. This is why they continue to use it. Agency materials also tie the model to public health aims, like understanding rising cases and improving shots. An agency summary cites baboon studies when discussing maternal vaccination and notes a previous baboon study that informed that work, showing a steady research line over years.
What The Baboon Experiments Have Shown So Far
Food and Drug Administration-affiliated scientists report that vaccinated baboons did not show classic whooping cough symptoms. But they still carried the bacteria and, in controlled studies, passed it to other baboons. That points to a clear gap: protection from severe disease does not always mean a stop to spread. The team highlighted that finding to explain community outbreaks despite vaccination and to steer work on next-generation vaccines.
Researchers also published early work that set the foundation for this program, stating the baboon model would help test licensed vaccines and build new tools. That paper described the model’s ability to mirror human infection and laid out plans to use it for vaccine evaluation and therapy development. The Food and Drug Administration’s later communications and scientific talks point back to these core results, underlining their influence on ongoing research choices.
Oversight, Protocols, And The Maryland Lab Context
Food and Drug Administration meeting materials list an approved support protocol comparing host responses to pertussis infection in baboons under different vaccines. The document shows an “Approved” status for a defined baboon research plan, which signals Institutional oversight and a formal path for experiments. It also references the agency’s research centers by name, indicating internal review steps that govern how and when animals can be used for pertussis studies.
Agency materials describe past work “in a baboon model” and a “previous study” using baboons, reflecting a continuing program rather than a one-off test. That context helps explain new animal acquisitions for Maryland-based infection work. The model’s value lies in tracking coughing, colonization, and spread, which are hard to measure in people. These are the precise features the Food and Drug Administration says are needed to answer why cases rise and how to stop transmission while still guarding the vulnerable.
What We Know And What The Public Still Cannot See
The public record supports the scientific utility claim for using baboons to study pertussis transmission. It shows that Food and Drug Administration-linked studies have shaped how experts view vaccine protection against disease versus spread. It also shows an approved internal baboon protocol. However, the available sources here do not include the purchase order, the vendor, the unit price, or the number and age of baboons tied to the Maryland experiments, which limits line-item scrutiny.
The bottom line for taxpayers is clear. Food and Drug Administration researchers say baboons are unique for studying coughing and spread, and they have published results that matter for vaccine policy and next steps. The program is active and has formal approval. At the same time, the absence of procurement details in the public set means citizens cannot yet review specific buying decisions. The scientific claims and the oversight record are public; the spending details are not.
Sources:
thegatewaypundit.com, pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov, fda.report
